HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prasanna Duraisamy Selected Research

Eczematous Skin Diseases

9/2022Tofacitinib in the treatment of refractory eczemas - a case series.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Prasanna Duraisamy Research Topics

Disease

2Skin Diseases (Skin Disease)
09/2022 - 07/2022
2Vitiligo
09/2022 - 04/2022
2Psoriasis (Pustulosis Palmaris et Plantaris)
09/2022 - 11/2021
1Dermatitis
09/2022
1Atopic Dermatitis (Atopic Eczema)
09/2022
1Alopecia Areata
09/2022
1Eczematous Skin Diseases
09/2022
1Bullous Pemphigoid (Pemphigoid)
07/2022
1Breast Neoplasms (Breast Cancer)
04/2022
1Hyperpigmentation
11/2021
1Granuloma
11/2021

Drug/Important Bio-Agent (IBA)

1tofacitinibIBA
09/2022
1Janus Kinase InhibitorsIBA
09/2022
1SteroidsIBA
09/2022
1Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA
07/2022
1Dipeptidyl-Peptidase IV InhibitorsIBA
07/2022
1Cyclin-Dependent Kinases (cdk Proteins)IBA
04/2022
1ribociclibIBA
04/2022
1Cyclin DIBA
04/2022
1MercuryIBA
11/2021

Therapy/Procedure

2Therapeutics
09/2022 - 04/2022
1Drug Substitution
07/2022